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Abstract
Brucellosis is an important public health problem in the Mediterranean countries,
including our country. Furthermore, because of different symptoms and clinical
findings, the disease could be confused with several other diseases. In this
article, three unusual findings of brucellosis are presented: pancytopenia,
endocarditis and meningitis.
K Ke ey y   w wo or rd ds s: :   brucellosis, endocarditis, meningitis, pancytopenia.
Introduction
Brucellosis remains the commonest zoonotic disease worldwide with
more than 500,000 new cases annually [1]. The symptoms of brucellosis
are non-specific; therefore, it may be difficult to diagnose [2]. The disease
may  be  overlooked  and  misdiagnosed  because  of  atypical  clinical
manifestations. The purpose of this paper is to emphasize atypical
presentations of brucellosis.
Case 1
A 26-year-old female presented with fever, night sweats, headache and
malaise for one week. The patient had been initially presented to a general
practitioner with the same symptoms five days before admission and given
antibiotic treatment (second-generation cephalosporin) and paracetamol. On
admission her vital signs were as follows: body temperature: 38.5°C, arterial
blood pressure: 70/30 mmHg, heart rate: 118/min and respiration rate: 14/min.
Physical examination revealed hepatosplenomegaly. Laboratory tests showed
haemoglobin: 10.2 g/dl, white blood cells: 2700/mm3 with polymorphs 35%,
lymphocytes 52%, monocytes 10% and eosinophils 3%. The platelet count
was 37 × 109/l. Erythrocyte sedimentation rate (ESR) was 32 mm in the first
hour. C-reactive protein (CRP) was 98 mg/dl. Brucella standard tube
agglutination (STA) test was negative (or 1/80 titre). Grubel-Widal and
monospot tests were negative. Blood and urine cultures were negative; three
blood cultures for Brucella were also negative after 14 days of incubation. On
day 6., Brucella spp. were isolated from bone marrow culture. Clinical and
haematological findings improved with the treatment of brucellosis with
streptomycin (1 g/d i.m.) and doxycycline (2 × 100 mg/d p.o.). 
Case 2
A 50-year-old male presented with malaise, fever, cough, night sweats
for ten days. On admission his vital signs were as follows: body
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Copyright © 2011 Termedia & Banachtemperature:  38.0°C,  arterial  blood  pressure:
110/70 mmHg, heart rate: 86/min, respiration rate
20/min. Physical examination revealed cardiac
murmur and hepato  splenomegaly. Laboratory
tests showed haemo  globin: 11.1 g/dl, white blood
cells: 15600/mm3, platelets: 406 × 109/mm3, CRP:
85 mg/dl, ESR: 44 mm/h, AST: 75 U/L (N: 0-31),
ALT:  21  U/L  (N:  0-34),  rheumatoid  factor: 
148 (N: 0-15) IU/ml. Echocar  diogram showed vege-
tation of 15 × 13 mm on posterior mitral leaflet.
STA was positive at a titre of 1/640. On day 4.,
Brucella spp. were isolated from blood culture.
The patient was put on treatment with doxy  -
cycline (200 mg/d p.o.), rifampicin (1 × 600 mg/d
p.o.) and ceftriaxone (2 × 1 g/d i.v.). The surgery
was planned for endocarditis.
Case 3
A 41-year-old male presented with fever and
confusion. On admission his vital signs were as
follows: body temperature: 38.5°C, arterial blood
pressure: 130/70 mmHg, heart rate: 87/min and
respiration rate: 18/min. On physical examination,
he had neck stiffness and confusion. Kernig’s and
Brudzenski’s  signs  were  negative  and  focal
neurological  signs  were  not  detected.  Blood
parameters revealed the following values: haemo  -
globin: 14 g/dl, white blood cells: 10600/mm3
(polymorphs 55%, lymphocytes 24%, monocytes
18%, eosinophils 3%); platelets: 223 × 109/mm3.
Serum  electrolytes,  creatinine  levels  and  liver
parameters were within normal limits. A lumbar
puncture  performed  on  admission  showed 
450  leucocytes/mm3.  The  Gram  staining  of
cerebrospinal fluid (CSF) was negative. Glucor  -
rhachia/glycaemia was 11/85 mg/dl and the protein
concentration was 271 mg/dl. The STA titre in CSF
was 1/10. A presumptive diagnosis of bacterial
meningitis  was  established.  Therapy  with
intravenous ceftriaxone (2 × 2 g/d) was initiated.
On day 8., Brucella spp. were isolated from CSF
culture. Doxycycline (200 mg/d) and rifampicin 
(1 × 600 mg/d) were added to the treatment.
Symptoms regressed with the treatment. 
Discussion
Brucellosis is a common zoonotic disease in
endemic areas such as Turkey. It is a disseminated
C Ca as se e   1 1 C Ca as se e   2 2 C Ca as se e   3 3
Age/Sex 26/F 50/M 41/M
Symptoms Fever, night sweats,  Fever, cough, night sweats,  Fever, confusion
headache, malaise malaise 
Pathological findings  Fever, hypotension,  Fever, cardiac murmur,  Fever, neck stiffness, 
hepatosplenomegaly hepatosplenomegaly confusion
Laboratory findings
Haemoglobin [g/dl] 10.2 11.1 14
White blood cells 2700/mm3 15600/mm3 10600/mm3
Platelet  37 × 109/mm3 406 × 109/mm3 223 × 109/mm3
CRP [mg/dl] 98 85 3.2
ESR [mm/h] 32  44
RF [IU/ml] 148
STA 1/80 1/640 1/10 (in CSF)
CSF  450 leucocytes/mm3
Glucorrhachia/glycaemia: 
11/85 mg/dl
Protein: 271 mg/dl
Echocardiogram Vegetation of 15 × 13 mm 
on posterior mitral leaflet
Culture Brucella spp. were isolated  Brucella spp. were isolated  Brucella spp. were isolated 
from bone marrow culture from blood culture from CSF culture
Treatment Doxycycline +  Doxycycline + rifampicin  Doxycycline +
streptomycin + ceftriaxone rifampicin + ceftriaxone
F – female, M – male, CRP – C-reactive protein, ESR – erythrocyte sedimentation rate, STA – standard tube agglutination, RF – rheumatoid factor,
CSF – cerebrospinal fluid
T Ta ab bl le e   I I. . Characteristics of the patients
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infection that may present with a broad spectrum
of clinical manifestations; therefore, it may be
difficult to diagnose [2]. 
The haematological abnormalities (leucopenia,
anemia, thrombocytopenia) are common in brucel  -
losis but pancytopenia is rare. The pathogenesis of
pancytopenia in brucellosis has not been clearly
understood, but it seems to be multifactorial.
Several possible mechanisms have been suggested
for pancytopenia caused by brucellosis, such as
hemophagocytosis, hyper  splenism, bone marrow
granulomas, bone marrow hypoplasia, and immune
destruction [3]. In presented case 1, pancytopenia
may be caused by hypersplenism. On the other
hand, blood culture is the gold standard in the
diagnosis of brucellosis. The sensitivity of blood
culture depends on several factors such as previous
use of antibiotics and phase of the disease. Bone
marrow cultures may provide higher sensitivity,
yield faster culture times, and may be superior to
blood  cultures  when  evaluating  patients  with
previous antibiotic use [4, 5]. In our case, blood
cultures were negative probably due to the used
antibiotic.
Endocarditis occurs in less than 2% of cases, but
it accounts for the majority of brucellosis-related
deaths [2, 6]. Brucella endocarditis may develop on
valves, previously damaged by rheumatic fever or
congenitally malformed, but may also occur on
previously normal valves. The clinical features are
distinguishable from those of endocarditis caused
by other organisms. The aortic valve is the most
commonly affected cardiac valve [2, 6]. In our case 2,
the mitral valve was affected. The diagnosis of
endocarditis was made in accordance with Duke’s
criteria. Brucellosis may lead to complications that
affect different organs and systems; among them
endocarditis is a rare but serious complication. 
Neurologic manifestations of brucellosis occur
in 5% of patients [4]. Among the clinical mani  -
festations, meningitis has been the most frequent
presentation in clinical series and usually presents
in an acute or chronic form. However, it has been
noted that < 40% of the patients with brucellar
meningitis exhibit meningeal signs. In our case, we
observed neck stiffness. The diagnosis of brucellar
meningitis  depends  on  the  demonstration  of
meningeal inflammation, abnormal CSF findings,
and direct or indirect evidence of Brucella in the CSF
[2, 7]. Cerebrospinal fluid analysis reveals a lym  -
phocytic pleocytosis, elevated protein content, and
low to normal glucose levels. Gram stains are
usually negative and cultures are positive in less
than  one  quarter  of  the  cases;  however,  the
diagnosis is based on the presence of specific
antibodies in the cerebrospinal fluid [2, 4]. In our
case, the diagnosis was made by microorganism
isolation at the CSF and the antibodies detection in
the CSF. 
In conclusion, brucellosis is an important health
problem especially in endemic areas. It may mimic
many diseases (infectious or non-infectious). In
patients living in endemic regions, considering
brucellosis in differential diagnosis may lead to early
diagnosis and treatment, and may decrease the
complications. 
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